A dozen plaintiffs have filed a Xarelto lawsuit in California alleging the blood thinning medication was responsible for serious complications they experienced. According to the complaint, which is currently pending in U.S. District Court, Central District of California, all of the plaintiffs named in the lawsuit experienced either gastrointestinal or rectal bleeding, and one suffered a stroke.

Law360.com reports that all of the individuals named in the California complaint were prescribed Xarelto to treat atrial fibrillation or to prevent blood clots. In some cases, the complications they experienced were serious enough to warrant hospitalization. The lawsuit notes that the complaint could potentially be transferred to the U.S. District Court, Eastern District of Pennsylvania, where dozens of similar Xarelto cases have been consolidated before a single judge for coordinated pretrial proceedings.

Like other Xarelto claims pending in U.S. courts, the California case alleges that the drug’s manufacturers failed to warn doctors and patients about its potential to cause life-threatening internal bleeding and other serious complications. Plaintiffs also assert that the companies misinformed doctors and patients by promising that the drug does not require frequent blood monitoring, which is standard for some other anticoagulants. Rather, they assert that Xarelto patients would benefit from such monitoring. Finally, they point out that there is currently no approved antidote for internal bleeding that sometimes occurs with Xarelto. By contrast, bleeding associated with an older drug called warfarin can be stopped via the administration of vitamin K.

Growing Xarelto Litigation

If this case is transferred to the federal multidistrict litigation in Louisiana, it would become one of more than 200 claims pending in that jurisdiction. In addition, at least 169 Xarelto lawsuits have been filed in a mass tort proceeding underway in Pennsylvania state court in Philadelphia, all of which allege similar injuries and make the same assertions about the way the medication was marketed.

The Xarelto lawyers at Bernstein Liebhard LLP are currently representing a number of individuals who were allegedly injured by this medication. If you or a loved one experienced internal bleeding, a stroke, deep vein thrombosis or pulmonary embolism while using Xarelto, please call 1-877-779-1414 to learn how you can join this growing litigation.

Published March 30, 2015 by